Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia

Huiqiong Deng, Ramandeep S. Kahlon, Satyajit Mohite, Pooja A. Amin, Giovana Zunta-Soares, Gabriela D. Colpo, Laura Stertz, Gabriel R. Fries, Consuelo Walss-Bass, Jair C. Soares, Olaoluwa O. Okusaga

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

S100B is a calcium binding protein mainly produced by glial cells. Previous studies have shown elevated levels of S100B in patients with schizophrenia. We measured S100B levels in fasting plasma of 39 patients with schizophrenia and 19 adult healthy controls. We used linear regression to compare S100B between patients and controls. In patients only, we also investigated the relationship between S100B levels and psychotic symptoms (assessed by the Positive and Negative Syndrome Scale), and cognitive function (assessed by the NIH Toolbox Cognition Battery), respectively by calculating Pearson’s correlation coefficients. Mean plasma S100B was significantly higher in the patient group than in the control group. There were no significant correlations between plasma S100B and psychotic symptoms or cognition.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalPsychiatric Quarterly
DOIs
StateAccepted/In press - Apr 24 2017
Externally publishedYes

Fingerprint

Cognition
Schizophrenia
Calcium-Binding Proteins
Neuroglia
Linear Models
Fasting
Control Groups

Keywords

  • Cognition
  • NIH toolbox cognition battery
  • Psychotic symptoms
  • S100B
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Deng, H., Kahlon, R. S., Mohite, S., Amin, P. A., Zunta-Soares, G., Colpo, G. D., ... Okusaga, O. O. (Accepted/In press). Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia. Psychiatric Quarterly, 1-8. https://doi.org/10.1007/s11126-017-9514-y

Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia. / Deng, Huiqiong; Kahlon, Ramandeep S.; Mohite, Satyajit; Amin, Pooja A.; Zunta-Soares, Giovana; Colpo, Gabriela D.; Stertz, Laura; Fries, Gabriel R.; Walss-Bass, Consuelo; Soares, Jair C.; Okusaga, Olaoluwa O.

In: Psychiatric Quarterly, 24.04.2017, p. 1-8.

Research output: Contribution to journalArticle

Deng, H, Kahlon, RS, Mohite, S, Amin, PA, Zunta-Soares, G, Colpo, GD, Stertz, L, Fries, GR, Walss-Bass, C, Soares, JC & Okusaga, OO 2017, 'Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia', Psychiatric Quarterly, pp. 1-8. https://doi.org/10.1007/s11126-017-9514-y
Deng H, Kahlon RS, Mohite S, Amin PA, Zunta-Soares G, Colpo GD et al. Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia. Psychiatric Quarterly. 2017 Apr 24;1-8. https://doi.org/10.1007/s11126-017-9514-y
Deng, Huiqiong ; Kahlon, Ramandeep S. ; Mohite, Satyajit ; Amin, Pooja A. ; Zunta-Soares, Giovana ; Colpo, Gabriela D. ; Stertz, Laura ; Fries, Gabriel R. ; Walss-Bass, Consuelo ; Soares, Jair C. ; Okusaga, Olaoluwa O. / Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia. In: Psychiatric Quarterly. 2017 ; pp. 1-8.
@article{e6b4ebe3e37546f1a53fc5ac2a8ac566,
title = "Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia",
abstract = "S100B is a calcium binding protein mainly produced by glial cells. Previous studies have shown elevated levels of S100B in patients with schizophrenia. We measured S100B levels in fasting plasma of 39 patients with schizophrenia and 19 adult healthy controls. We used linear regression to compare S100B between patients and controls. In patients only, we also investigated the relationship between S100B levels and psychotic symptoms (assessed by the Positive and Negative Syndrome Scale), and cognitive function (assessed by the NIH Toolbox Cognition Battery), respectively by calculating Pearson’s correlation coefficients. Mean plasma S100B was significantly higher in the patient group than in the control group. There were no significant correlations between plasma S100B and psychotic symptoms or cognition.",
keywords = "Cognition, NIH toolbox cognition battery, Psychotic symptoms, S100B, Schizophrenia",
author = "Huiqiong Deng and Kahlon, {Ramandeep S.} and Satyajit Mohite and Amin, {Pooja A.} and Giovana Zunta-Soares and Colpo, {Gabriela D.} and Laura Stertz and Fries, {Gabriel R.} and Consuelo Walss-Bass and Soares, {Jair C.} and Okusaga, {Olaoluwa O.}",
year = "2017",
month = "4",
day = "24",
doi = "10.1007/s11126-017-9514-y",
language = "English (US)",
pages = "1--8",
journal = "Psychiatric Quarterly",
issn = "0033-2720",
publisher = "Kluwer Academic/Human Sciences Press Inc.",

}

TY - JOUR

T1 - Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia

AU - Deng, Huiqiong

AU - Kahlon, Ramandeep S.

AU - Mohite, Satyajit

AU - Amin, Pooja A.

AU - Zunta-Soares, Giovana

AU - Colpo, Gabriela D.

AU - Stertz, Laura

AU - Fries, Gabriel R.

AU - Walss-Bass, Consuelo

AU - Soares, Jair C.

AU - Okusaga, Olaoluwa O.

PY - 2017/4/24

Y1 - 2017/4/24

N2 - S100B is a calcium binding protein mainly produced by glial cells. Previous studies have shown elevated levels of S100B in patients with schizophrenia. We measured S100B levels in fasting plasma of 39 patients with schizophrenia and 19 adult healthy controls. We used linear regression to compare S100B between patients and controls. In patients only, we also investigated the relationship between S100B levels and psychotic symptoms (assessed by the Positive and Negative Syndrome Scale), and cognitive function (assessed by the NIH Toolbox Cognition Battery), respectively by calculating Pearson’s correlation coefficients. Mean plasma S100B was significantly higher in the patient group than in the control group. There were no significant correlations between plasma S100B and psychotic symptoms or cognition.

AB - S100B is a calcium binding protein mainly produced by glial cells. Previous studies have shown elevated levels of S100B in patients with schizophrenia. We measured S100B levels in fasting plasma of 39 patients with schizophrenia and 19 adult healthy controls. We used linear regression to compare S100B between patients and controls. In patients only, we also investigated the relationship between S100B levels and psychotic symptoms (assessed by the Positive and Negative Syndrome Scale), and cognitive function (assessed by the NIH Toolbox Cognition Battery), respectively by calculating Pearson’s correlation coefficients. Mean plasma S100B was significantly higher in the patient group than in the control group. There were no significant correlations between plasma S100B and psychotic symptoms or cognition.

KW - Cognition

KW - NIH toolbox cognition battery

KW - Psychotic symptoms

KW - S100B

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=85018845730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018845730&partnerID=8YFLogxK

U2 - 10.1007/s11126-017-9514-y

DO - 10.1007/s11126-017-9514-y

M3 - Article

SP - 1

EP - 8

JO - Psychiatric Quarterly

JF - Psychiatric Quarterly

SN - 0033-2720

ER -